Combination radioprotectors maintain proliferation better than single agents by decreasing early parathyroid hormone-related protein changes after growth plate irradiation

Radiation Research

Volumn 165, Issue 3, 2006, Pages 350-358

  Damron, Timothy A ^a,c   Horton, Jason A ^a   Naqvi, Asghar ^a   Loomis, Richard M ^a   Margulies, Bryan S ^a   Strauss, Judith A ^a   Farnum, Cornelia E ^b   Spadaro, Joseph A ^a  

^a State University of New York Upstate Medical University: College of Medicine   (United States)

^b Animal Health Diagnostic Center   (United States)

^c SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIFOSTINE; BROXURIDINE; CYTOKINE; MISOPROSTOL; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE RELATED PROTEIN; PENTOXIFYLLINE; PROTEIN BAX; PROTEIN BCL 2; RADIOPROTECTIVE AGENT; SONIC HEDGEHOG PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; GROWTH PLATE; HINDLIMB; MALE; MONOTHERAPY; NONHUMAN; POLYPHARMACY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RAT; TREATMENT OUTCOME; X RAY;

ANIMALS; CASPASE 3; CASPASES; CELL PROLIFERATION; EXTREMITIES; GROWTH PLATE; IMMUNOHISTOCHEMISTRY; MALE; PARATHYROID HORMONE-RELATED PROTEIN; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PARATHYROID HORMONE; TIME FACTORS;

ANIMALIA; ERINACEIDAE;

EID: 33644528722     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/RR3504.1     Document Type: Article

References (48)

1. J. A. Reidy, J. R. Lingley, E. A. Gall and J. S. Barr, The effect of roentgen irradiation on epiphyseal growth: II. Experimental studies on the dog. J. Bone Joint Surg. 29, 853-873 (1947).
2. J. Blackburn and B. A. Wells, Radiation damage to growing bone: The effect of x-ray doses of 100 to 1000 r on mouse tibia and knee-joint. Br. J. Radiol. 36, 505-513 (1963).
3. J. S. Barr, J. R. Lingley and E. A. Gall, The effect of roentgen irradiation on epiphyseal growth: I. Experimental studies on the albino rat. Am. J. Roentgenol. 49, 104-115 (1943).
4. B. Brooks and H. T. Hillstrom, Effect of roentgen rays on bone growth and bone regeneration. Am. J. Surg. 20, 599-614 (1933).
5. M. S. Butler, W. W. Robertson, Jr., W. Rate, G. J. D'Angio and D. S. Drummond, Skeletal sequelae of radiation therapy for malignant childhood tumors. Clin. Orthop. 251, 235-240 (1990).
6. J. W. Goldwein, Effects of radiation therapy on skeletal growth in childhood. Clin. Orthop. 262, 101-107 (1991).
7. C. L. Hinkel, The effect of roentgen rays upon the growing long bones of albino rats: I. Quantitative studies of the growth limitation following irradiation. Am. J. Roentgenol. 47, 439-457 (1942).
8. C. L. Hinkel, The effect of roentgen rays upon the growing long bones of albino rats: II. Histopathological changes involving endochondral growth centers. Am. J. Roentgenol. 49, 312-348 (1943).
9. E. M. Regen and W. E. Wilkens, The effect of large doses of x-rays on the growth of young bone. J. Bone Joint Surg. 18, 61-68 (1936).
10. W. W. Robertson, Jr., M. S. Butler, G. J. D'Angio and W. R. Rate, Leg length discrepancy following irradiation for childhood tumors. J. Pediatr. Orthop. 11, 284-287 (1991).
11. A. Raza, H. Qawi, L. Lisak, T. Andric, S. Dar, C. Andrews, P. Venugopal, S. Gezer, S. Gregory, J. Loew, E. Robin, S. Rifkin, W. T. Hsu and R. W. Huang, Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone. Blood 95, 1580-1587 (2000).
12. T. K. Gosselin and B. Mautner, Amifostine as a radioprotectant. Clin. J. Oncol. Nurs. 6, 175-176 (2002).
13. D. J. Grdina, Y. Kataoka and J. S. Murley, Amifostine: Mechanisms of action underlying cytoprotection and chemoprevention. Drug Metabol. Drug Interact. 16, 237-279 (2000).
14. W. R. Hanson and D. J. Grdina, Misoprostol, a PGE1 analog, protects mice from fission-neutron injury. Radiat. Res. 128, 12-17 (1991).
15. R. Komaki, J. S. Lee, L. Milas, H. K. Lee, F. V. Fossella, R. S. Herbst, P. K. Allen, Z. Liao, C. W. Stevens and J. D. Cox, Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: Report of a randomized comparative trial. Int. J. Radiat. Oncol. Biol. Phys. 58, 1369-1377 (2004).
16. J. L. Lefaix, S. Delanian, J. J. Leplat, Y. Tricaud, M. Martin, A. Nimrod, F. Baillet and F. Daburon, Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: An experimental study. Int. J. Radiat. Oncol. Biol. Phys. 35, 305-312 (1996).
17. A. F. List, Use of amifostine in hematologic malignancies, myelodysplastic syndrome, and acute leukemia. Semin. Oncol. 26 (Suppl. 7), 61-65 (1999).
18. T. Liu, Y. Liu and S. He, Use of radiation with or without WR-2721 in advanced rectal cancer. Cancer 69, 2820-2825 (1992).
19. M. P. Mehta, Protection of normal tissues from the cytotoxic effects of radiation therapy. Focus on amifostine. Semin. Radiat. Oncol. 8 (Suppl. 1), 14-16 (1998).
20. U. Mutlu-Turkoglu, Y. Erbil, S. Oztezcan, V. Olgac, G. Toker and M. Uysal, The effect of selenium and/or vitamin E treatments on radiation-induced intestinal injury in rats. Life Sci. 66, 1905-1913 (2000).
21. R. Neta, S. D. Douches and J. J. Oppenheim, Interleukin-1 is a radioprotector. J. Immunol. 136, 2483-2485 (1986).
22. P. Okunieff, M. Li, W. Liu, J. Sun, B. Fenton, L. Zhang and I. Ding, Keratinocyte growth factors radioprotect bowel and bone marrow but not KHT sarcoma. Am. J. Clin. Oncol. 24, 491-495 (2001).
23. P. Okunieff, M. Mester, J. Wang, T. Maddox, X. Gong, D. Tang, M. Coffee and I. Ding, in vivo radioprotective effects of angiogenic growth factors on the small bowel of C3H mice. Radiat. Res. 150, 204-211 (1998).
24. M. Patchen, Immunomodulators and cytokines: Their use in the mitigation of radiation-induced hemopoietic injury. In Radioprotectors: Chemical, Biological, and Clinical Perspectives (E. A. Bump and K. Malaker, Eds.), pp. 213-236. CRC Press, Boca Raton, FL, 1997.
25. J. R. Sorenson, Cu, Fe, Mn, and Zn chelates offer a medicinal chemistry approach to overcoming radiation injury. Curr. Med. Chem. 9, 639-662 (2002).
26. J. Weiss, R. Hoover and K. Kumar, Selenium pretreatment enhances the radioprotective effect and reduces the lethal toxicity of WR-2721. Free Radic. Res. Commun. 3, 33-38 (1987).
27. J. Weiss, V. Srinivasan, K. Kumar and M. Landauer, Radioprotection by metals: Selenium. Adv. Space Res. 12, 223-231 (1992).
28. T. Damron, J. Spadaro, J. Horton, B. Margulies, J. Strauss and C. Farnum, Novel radioprotectant drugs for sparing radiation-induced damage to the physis. Int. J. Radiat. Biol. 80, 217-228 (2004).
29. T. A. Damron, B. Margulies, D. Biskup and J. A. Spadaro, Amifostine before fractionated irradiation protects bone growth in rats better than fractionation alone. Int. J. Radiat. Oncol. Biol. Phys. 50, 479-483 (2001).
30. T. A. Damron, S. Mathur, J. A. Horton, J. Strauss, B. Margulies, W. Grant, C. E. Farnum and J. A. Spadaro, Temporal changes in PTHrP, Bcl-2, Bax, caspase, TGF-beta, and FGF-2 expression following growth plate irradiation with or without radioprotectant. J. Histochem. Cytochem. 52, 157-167 (2004).
31. T. A. Damron, J. A. Spadaro, J. A. Horton, B. Margulies, J. A. Strauss and C. E. Farnum, Combinations of radioprotectants spare radiation-induced damage to the physis. Clin. Orthop. Relat. Res. 426, 110-116 (2004).
32. R. M. Tamurian, T. A. Damron and J. A. Spadaro, Sparing radiation-induced damage to the physis by radioprotectant drugs: Laboratory analysis in a rat model. J. Orthop. Res. 17, 286-292 (1999).
33. J. F. Weiss, K. S. Kumar, T. L. Walden, R. Neta, M. R. Landauer and E. P. Clark, Advances in radioprotection through the use of combined agent regimens. Int. J. Radiat. Biol. 57, 709-722 (1990).
34. T. A. Damron, J. A. Horton, A. Naqvi, B. Margulies, J. Strauss, C. E. Farnum and J. A. Spadaro, Decreased proliferation precedes growth factor changes after physical irradiation. Clin. Orthop. Relat. Res. 422, 233-242 (2004).
35. T. Damron, B. Margulies, J. Strauss, K. O'Hara, J. Spadaro and C. Farnum, Sequential histomorphometry of the growth plate following irradiation with and without radioprotection. J. Bone Joint Surg. 85-A, 1302-1313 (2003).
36. P. J. Eifel, Decreased bone growth arrest in weanling rats with multiple radiation fractions per day. Int. J. Radiat. Oncol. Biol. Phys. 15, 141-145 (1988).
37. B. S. Margulies, H. Morgan, M. J. Allen, J. Strauss, J. A. Spadaro and T. A. Damron, Transiently increased bone density following irradiation and the radioprotectant drug amifostine in a rat model. Am. J. Clin. Oncol. Clin. Cancer Trials 26, 106-114 (2003).
38. J. A. Spadaro, M. T. Baesl, A. C. Conta, B. S. Margulies and T. A. Damron, Effects of irradiation on the appositional and longitudinal growth of the tibia and fibula of the rat with and without radioprotectant. J. Pediatr. Orthop. 23, 35-40 (2003).
39. P. J. Eifel, C. M. Sampson and S. L. Tucker, Radiation fractionation sensitivity of epiphyseal cartilage in a weanling rat model. Int. J. Radiat. Oncol. Biol. Phys. 19, 661-664 (1990).
40. N. J. Wilsman, C. E. Farnum, E. M. Leiferman, M. Fry and C. Barreto, Differential growth by growth plates as a function of multiple parameters of chondrocytic kinetics. J. Orthop. Res. 14, 927-936 (1996).
41. C. E. Farnum and N. J. Wilsman, Determination of proliferative characteristics of growth plate chondrocytes by labeling with bromodeoxyuridine. Calcif. Tissue Int. 52, 110-119 (1993).
42. B. C. van der Eerden, M. Karperien, E. F. Gevers, C. W. Lowik and J. M. Wit, Expression of Indian hedgehog, parathyroid hormone-related protein, and their receptors in the postnatal growth plate of the rat: evidence for a locally acting growth restraining feedback loop after birth. J. Bone Miner. Res. 15, 1045-1055 (2000).
43. B. C. van der Eerden, M. Karperien and J. M. Wit, Systemic and local regulation of the growth plate. Endocr. Rev. 24, 782-801 (2003).
44. D. B. Pateder, R. N. Rosier, E. M. Schwarz, P. R. Reynolds, J. E. Puzas, M. D'Souza and R. J. O'Keefe, PTHrP expression in chondrocytes, regulation by TGF-beta, and interactions between epiphyseal and growth plate chondrocytes. Exp. Cell. Res. 256, 555-562 (2000).
45. Y. Kawashima-Ohya, H. Satakeda, Y. Kuruta, T. Kawamoto, W. Yan, Y. Akagawa, T. Hayakawa, M. Noshiro, Y. Okada and Y. Kato, Effects of parathyroid hormone (PTH) and PTH-related peptide on expressions of matrix metalloproteinase-2, -3, and -9 in growth plate chondrocyte cultures. Endocrinology 139, 2120-2127 (1998).
46. H. M. Scheres, A. F. De Goeij, M. J. Rousch, G. G. Hondius, D. D. Willebrand, A. H. Gijzen and F. T. Bosman, Quantification of oestrogen receptors in breast cancer: Radiochemical assay on cytosols and cryostat sections compared with semiquantitative immunocytochemical analysis. J. Clin. Pathol. 41, 623-632 (1988).
47. K. S. McCarty, Jr., L. S. Miller, E. B. Cox, J. Konrath and K. S. McCarty, Sr., Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch. Pathol. Lab. Med. 109, 716-721 (1985).
48. F. T. Bosman, A. F. de Goeij and M. Rousch, Quality control in immunocytochemistry: experiences with the oestrogen receptor assay. J. Clin. Pathol. 45, 120-124 (1992).